Skip to content

Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care

Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02545257
Enrollment
191
Registered
2015-09-09
Start date
2015-09-30
Completion date
2018-12-31
Last updated
2019-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Therapy, Combination, Inappropriate Prescribing, Polypharmacy

Keywords

Aged people, Home care, Drug related problems, DRPs, Coordinated medication management model

Brief summary

The objective of this randomized controlled trial is to develop a coordinated, multiprofessional medication management model for home-dwelling aged in primary care and to study the effectiveness of this model. The main hypothesis is that the new model helps to identify aged people having potential risks with their medications and thus allows solving these risks.

Detailed description

The demand for long-term home health care services is increasing due the demographic and societal developments. Aged people needing home care are increasingly older, have many chronic diseases and use multiple medicines and thus, are at high risk for drug-related problems (DRPs). In Finland, national and local healthcare and aged care strategies target to allowing aged people (over 65 years) living in their own homes as long as possible. This minimizes the costs of institutionalized care and also targets to add the quality of life of aged people. New approaches and service models are needed to meet these challenges. The present study focuses on the development of a coordinated medication management model which aims to ensure the safe medication practises for home-dwelling aged in primary care. In the previous parts of this study project were developed a model for comprehensive medication review process (CMR) and a Drug-Related Problem Risk Assessment Tool. The present study uses a multistage intervention in which medications are reviewed (prescription review) in a community pharmacy using the SFINX-database to identify clinically significant drug-drug interactions and the Salko-database which identifies potentially inappropriate medications for aged people. In the next stage practical nurses use the Drug-Related Problem Risk Assessment Tool to identify potential risks. The following stages are based on the results from the risk assessment tool. Potential options are, e.g.,physician consultation, more frequent home care visits, counselling given by the community pharmacy or comprehensive medication review (CMR). The CMR process is only targeted to a limited group of study participants with clinically significant DRP who probably will benefit from more comprehensive CMR.

Interventions

OTHERCoordinated medication management model

Stage I: a prescription review conducted by community pharmacists Stage II: practical nurse-administered Drug-related Problem Risk Assessment Tool Stage III: Required health care action based on the result of the DRP -Risk Assessment Tool

Sponsors

City of Lohja, Services for Aged People
CollaboratorUNKNOWN
Lohjan 1. Apteekki
CollaboratorOTHER
Social Insurance Institution, Finland
CollaboratorOTHER
University of Helsinki
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Home-dwelling over 65 year-old persons receiving regular home care from the City of Lohja

Exclusion criteria

* Home care is not given regularly

Design outcomes

Primary

MeasureTime frameDescription
Potentially inappropriate medicines (PIM) (Clinically significant drug-drug interactions, potentially inappropriate medicines for aged), identified from medication list review chartChange from baseline at 12 and 24 monthsPIMs are identified with prescription review using SFINX database (clinically significant drug-drug interactions) and Salko database (e.g., for identifying potentially inappropriate medicines for the aged, anticholinergic and serotonergic load).
AUDIT-C (Alcohol Use Disorder Identification Test, version C)Change from baseline at 12 and 24 months
UDI-6 (Urinary Distress Inventory)Change from baseline at 12 and 24 months
Rava (Functioning and disability, Finnish Consulting Group)Change from baseline at 12 and 24 months
GDS-15 (Geriatric Depression Scale)Change from baseline at 12 and 24 months
MMSE (Mini-Mental State Examination)Change from baseline at 12 and 24 monthsCognitive ability
MNA (Malnutrition Assessment)Change from baseline at 12 and 24 months
Time to rise from a chair and return to the seated position 5 times (Lower extremity function).Change from baseline at 12 and 24 months
Orthostatic hypotension (Short test, Freeman et al. 2011)Change from baseline at 12 and 24 months

Secondary

MeasureTime frameDescription
Use of health care services: hospital daysat 12 and 24 months from baselineNumber of hospital days (previous 3 months)
Use of health care services: home care servicesat 12 and 24 months from baselineServices delivered to home (previous 3 months)
Use of health care services: visits to physicianat 12 and 24 months from baselineNumber of visits (previous 3 months)

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026